We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$64.6B
AUM Growth
+$1.37B
Cap. Flow
-$686M
Cap. Flow %
-1.06%
Top 10 Hldgs %
38.17%
Holding
995
New
43
Increased
362
Reduced
491
Closed
59

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$36.3M
2
SCHW
Charles Schwab
SCHW
+$36.1M
3
ASND icon
Ascendis Pharma A/S
ASND
+$35.6M
4
DHR icon
Danaher
DHR
+$30.5M
5
QURE icon
uniQure
QURE
+$28.5M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$93.5M
2
MELI icon
Mercado Libre
MELI
+$86M
3
MSFT icon
Microsoft
MSFT
+$62.9M
4
AAPL icon
Apple
AAPL
+$55.6M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$48.9M

Sector Composition

Rank Sector Weight
1 Technology 32.59%
2 Healthcare 13.39%
3 Consumer Discretionary 11.41%
4 Communication Services 11.25%
5 Financials 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
951
DELISTED
Centessa Pharmaceuticals
CNTA
– –
-53,574
Closed -$1.3M
COWZ icon
952
Pacer US Cash Cows 100 ETF
COWZ
$19B
– –
-19,188
Closed -$1.1M
CSTM icon
953
Constellium
CSTM
$3.76B
– –
-112,533
Closed -$1.69M
EMN icon
954
Eastman Chemical
EMN
$7.69B
– –
-6,539
Closed -$410K
EXAS
955
DELISTED
Exact Sciences
EXAS
– –
-304,609
Closed -$16.7M
HPP
956
Hudson Pacific Properties
HPP
$758M
– –
-300,638
Closed -$5.75M
IAS
957
DELISTED
Integral Ad Science
IAS
– –
-335,915
Closed -$3.42M
NBP
958
NovaBridge Biosciences American Depositary Shares
NBP
$186M
– –
-43,738
Closed -$165K
INDV icon
959
Indivior Pharmaceuticals
INDV
$4.74B
– –
-160,717
Closed -$3.87M
IOT icon
960
Samsara
IOT
$22.6B
– –
-12,135
Closed -$452K
IPG
961
DELISTED
Interpublic Group of Companies
IPG
– –
-27,588
Closed -$747K
JANX icon
962
Janux Therapeutics
JANX
$912M
– –
-345,476
Closed -$8.44M
K
963
DELISTED
Kellanova
K
– –
-288,477
Closed -$23.6M
KMX icon
964
CarMax
KMX
$8.39B
– –
-8,733
Closed -$395K
KRRO icon
965
Korro Bio
KRRO
$145M
– –
-57,983
Closed -$2.78M
LKQ icon
966
LKQ Corp
LKQ
$6.72B
– –
-14,759
Closed -$451K
LRN icon
967
Stride
LRN
$4.16B
– –
-133,763
Closed -$20M
LZB icon
968
La-Z-Boy
LZB
$1.64B
– –
-358,447
Closed -$12.4M
MDU icon
969
MDU Resources
MDU
$4.18B
– –
-345,598
Closed -$6.14M
MHK icon
970
Mohawk Industries
MHK
$6.91B
– –
-3,011
Closed -$386K
MOAT icon
971
VanEck Morningstar Wide Moat ETF
MOAT
$11.8B
– –
-12,008
Closed -$1.18M
MREO
972
Mereo BioPharma
MREO
$48.9M
– –
-5,538,699
Closed -$11.4M
MRUS
973
DELISTED
Merus
MRUS
– –
-155,151
Closed -$14.6M
NICE icon
974
Nice
NICE
$6.15B
– –
-1,975
Closed -$286K
NTNX icon
975
Nutanix
NTNX
$16.1B
– –
-5,163
Closed -$384K
36 37 38
39
40

Similar funds

Mitsubishi UFJ Financial Group
Mitsubishi UFJ Financial Group Tokyo, Japan $62.1B AUM 41.06% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Aberdeen Group's Q4 2025 Portfolio in Review

As of Q4 2025, Aberdeen Group held 995 positions worth $64.6B, up 2.2% from $63.2B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Aberdeen Group's Q4 2025 filing shows 43 new, 362 increased, 491 reduced and 59 closed positions. Its largest new stake was Praxis Precision Medicines: 134,992 shares worth $39.8M. The largest sale was Eli Lilly, an estimated $93.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aberdeen Group's largest Q4 2025 buy was Praxis Precision Medicines: 134,992 shares worth $39.8M.
  • Aberdeen Group added most to Nu Holdings in Q4 2025, an estimated $36.3M increase.
  • Aberdeen Group's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $93.5M.
  • Aberdeen Group fully exited BioMarin Pharmaceuticals in Q4 2025, selling an estimated $48.9M.
  • Aberdeen Group's ten largest holdings make up 38% of its $64.6B portfolio in Q4 2025.
  • Aberdeen Group opened 43 new positions and closed 59 in Q4 2025.
  • Aberdeen Group's portfolio value rose 2.2% quarter-over-quarter to $64.6B.

Based on Aberdeen Group's 13F filing for Q4 2025, filed 16 Jan 2026.